These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 24124465)
1. Signaling via class IA Phosphoinositide 3-kinases (PI3K) in human, breast-derived cell lines. Juvin V; Malek M; Anderson KE; Dion C; Chessa T; Lecureuil C; Ferguson GJ; Cosulich S; Hawkins PT; Stephens LR PLoS One; 2013; 8(10):e75045. PubMed ID: 24124465 [TBL] [Abstract][Full Text] [Related]
2. A beta version of life: p110β takes center stage. Dbouk HA; Backer JM Oncotarget; 2010 Dec; 1(8):729-733. PubMed ID: 21321382 [TBL] [Abstract][Full Text] [Related]
3. Quantitation of class IA PI3Ks in mice reveals p110-free-p85s and isoform-selective subunit associations and recruitment to receptors. Tsolakos N; Durrant TN; Chessa T; Suire SM; Oxley D; Kulkarni S; Downward J; Perisic O; Williams RL; Stephens L; Hawkins PT Proc Natl Acad Sci U S A; 2018 Nov; 115(48):12176-12181. PubMed ID: 30442661 [TBL] [Abstract][Full Text] [Related]
4. Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. Geering B; Cutillas PR; Nock G; Gharbi SI; Vanhaesebroeck B Proc Natl Acad Sci U S A; 2007 May; 104(19):7809-14. PubMed ID: 17470792 [TBL] [Abstract][Full Text] [Related]
5. Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. Kang S; Denley A; Vanhaesebroeck B; Vogt PK Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1289-94. PubMed ID: 16432180 [TBL] [Abstract][Full Text] [Related]
6. Regulation of the PI3K pathway through a p85α monomer-homodimer equilibrium. Cheung LW; Walkiewicz KW; Besong TM; Guo H; Hawke DH; Arold ST; Mills GB Elife; 2015 Jul; 4():e06866. PubMed ID: 26222500 [TBL] [Abstract][Full Text] [Related]
7. The LCLAT1/LYCAT acyltransferase is required for EGF-mediated phosphatidylinositol-3,4,5-trisphosphate generation and Akt signaling. Chan V; Camardi C; Zhang K; Orofiamma LA; Anderson KE; Hoque J; Bone LN; Awadeh Y; Lee DKC; Fu NJ; Chow JTS; Salmena L; Stephens LR; Hawkins PT; Antonescu CN; Botelho RJ Mol Biol Cell; 2024 Sep; 35(9):ar118. PubMed ID: 39024272 [TBL] [Abstract][Full Text] [Related]
8. Leptin-dependent phosphorylation of PTEN mediates actin restructuring and activation of ATP-sensitive K+ channels. Ning K; Miller LC; Laidlaw HA; Watterson KR; Gallagher J; Sutherland C; Ashford ML J Biol Chem; 2009 Apr; 284(14):9331-40. PubMed ID: 19208634 [TBL] [Abstract][Full Text] [Related]
9. Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN. Taniguchi CM; Tran TT; Kondo T; Luo J; Ueki K; Cantley LC; Kahn CR Proc Natl Acad Sci U S A; 2006 Aug; 103(32):12093-7. PubMed ID: 16880400 [TBL] [Abstract][Full Text] [Related]
10. Type I phosphoinositide 3-kinases: potential antithrombotic targets? Jackson SF; Schoenwaelder SM Cell Mol Life Sci; 2006 May; 63(10):1085-90. PubMed ID: 16649145 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylation at tyrosine 317 and 508 are crucial for PIK3CA/p110α to promote CRC tumorigenesis. Wang T; Sun L; Chen C; Zhang Y; He B; Zhang Y; Wang Z; Xue H; Hao Y Cell Biosci; 2023 Sep; 13(1):164. PubMed ID: 37689735 [TBL] [Abstract][Full Text] [Related]
13. RAS interaction with PI3K p110α is required for tumor-induced angiogenesis. Murillo MM; Zelenay S; Nye E; Castellano E; Lassailly F; Stamp G; Downward J J Clin Invest; 2014 Aug; 124(8):3601-11. PubMed ID: 25003191 [TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide 3-kinase (PI3K(p110alpha)) directly regulates key components of the Z-disc and cardiac structure. Waardenberg AJ; Bernardo BC; Ng DCH; Shepherd PR; Cemerlang N; Sbroggiò M; Wells CA; Dalrymple BP; Brancaccio M; Lin RCY; McMullen JR J Biol Chem; 2011 Sep; 286(35):30837-30846. PubMed ID: 21757757 [TBL] [Abstract][Full Text] [Related]
15. Calpain interacts with class IA phosphoinositide 3-kinases regulating their stability and signaling activity. Beltran L; Chaussade C; Vanhaesebroeck B; Cutillas PR Proc Natl Acad Sci U S A; 2011 Sep; 108(39):16217-22. PubMed ID: 21930956 [TBL] [Abstract][Full Text] [Related]
16. Class (I) Phosphoinositide 3-Kinases in the Tumor Microenvironment. Gyori D; Chessa T; Hawkins PT; Stephens LR Cancers (Basel); 2017 Mar; 9(3):. PubMed ID: 28273837 [TBL] [Abstract][Full Text] [Related]
17. Rules of engagement: distinct functions for the four class I PI3K catalytic isoforms in immunity. Okkenhaug K Ann N Y Acad Sci; 2013 Mar; 1280():24-6. PubMed ID: 23551098 [TBL] [Abstract][Full Text] [Related]
18. Paradoxical dominant negative activity of an immunodeficiency-associated activating Tomlinson PR; Knox R; Perisic O; Su HC; Brierley GV; Williams RL; Semple RK bioRxiv; 2023 Dec; ():. PubMed ID: 38077044 [No Abstract] [Full Text] [Related]
19. The PI3K Pathway in Human Disease. Fruman DA; Chiu H; Hopkins BD; Bagrodia S; Cantley LC; Abraham RT Cell; 2017 Aug; 170(4):605-635. PubMed ID: 28802037 [TBL] [Abstract][Full Text] [Related]
20. Multimodal action of KRP203 on phosphoinositide kinases in vitro and in cells. Ikeda Y; Davis MI; Sumita K; Zheng Y; Kofuji S; Sasaki M; Hirota Y; Pragani R; Shen M; Boxer MB; Takeuchi K; Senda T; Simeonov A; Sasaki AT Biochem Biophys Res Commun; 2023 Oct; 679():116-121. PubMed ID: 37683456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]